Cancer Pharmacology Research Program

Program Leaders: X. F. Steven Zheng, PhD and Stephen K. Burley, MD, DPhil
 

Overall Goals:

The overarching goal of the Cancer Pharmacology (CP) Program is discovery and development of more effective cancer treatments through pharmacology-based preclinical research and technical innovation.
 

Specific Aims:

  • To understand the biology of key molecular targets in cancer that drive cell growth, proliferation, and survival so that they can be effectively exploited for cancer therapy.
  • To determine the modes of action and mechanisms of resistance to anticancer agents.
  • To discover and develop novel therapeutics and drug delivery technologies for more effective cancer treatment.
     

Collaborating Research Programs:

Useful Links:

 

Impact of PDB Structures on Anti-Cancer Drug Approvals PDF thumbnail

Impact of PDB Structures on Anti-Cancer Drug Approvals
(click to enlarge PDF)